• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® LYME IGG II 60 TESTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® LYME IGG II 60 TESTS Back to Search Results
Model Number 417401
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in the united states notified biomérieux of obtaining a false negative result for a patient sample in association with the vidas® lyme igg 60 tests (ref 417401, lot 1007326720).The customer tested the patient sample using vidas® lyme igg 60 tests which obtained a result of negative.The customer also tested the sample using line blot and sofia test method, both assays yielded a result of positive for both samples.There is no indication or report from the laboratory that the discrepant results led to any adverse event related to the patient's state of health.Biomérieux will initiate an internal investigation.
 
Manufacturer Narrative
An investigation was initiated in response to a customer complaint of a false negative result for a patient sample in association with the vidas® lyme igg 60 tests (ref 417401, lot 1007326720).The customer was unable to submit the sample for investigational testing.There have been no other complaints registered for this type of issue for this lot.An internal study was conducted with internal samples on 13 different batches of vidas® lyme igg, including the customers lot (1007326720).The analysis of the control charts showed that all results were within specifications, customer¿s lot was in the trend of the other lots.Two (2) negative samples and three (3) positive samples were tested on lot 1007326720 all results were compliant to specifications.Without the customer's sample, no root cause was able to be established.The internal study did not identify any issue with the customer's lot of vidas® lyme igg 60 tests (ref 417401, lot 1007326720).See h10 for addtl mfg narrative.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® LYME IGG II 60 TESTS
Type of Device
VIDAS® LYME IGG II 60 TESTS
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile 69280
FR  69280
MDR Report Key9649657
MDR Text Key207751490
Report Number8020790-2020-00009
Device Sequence Number1
Product Code LSR
UDI-Device Identifier03573026458270
UDI-Public03573026458270
Combination Product (y/n)N
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 04/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/30/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/21/2020
Device Model Number417401
Device Catalogue Number417401
Device Lot Number1007326720
Was Device Available for Evaluation? No
Date Manufacturer Received03/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-